Asset
Solriamfetol hydrochloride
Axsome Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 211230 | NDA | AXSOME MALTA LTD |
Marketed products (2)
- SUNOSI
- SUNOSI